Bay Street News, August, 2020

Pegzilarginase Showed Durable Clinical Response and Sustained Reduction in Plasma Arginine at 56 Week Analysis of Phase 1/2 Open-Label Extension StudyInitiated […]

Early Interim Data from Registrational Phase 2 TRIDENT-1 Study of Lead Drug Candidate Repotrectinib Anticipated in Third QuarterFour Clinical Studies […]

NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — Datasea Inc. (NASDAQ: DTSS) (“Datasea” or the “Company”), a technology company engaged in providing […]

TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) — CCL Industries Inc. (TSX:CCL.A) (TSX:CCL.B), a world leader in specialty label, security and […]

BELGRADE, Mont., Aug. 10, 2020 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused […]

TORONTO, Aug. 10, 2020 (GLOBE NEWSWIRE) — Trigon Metals Inc. (TSX-V: TM) (“Trigon” or the “Company”) is pleased to report […]

Net Revenues of $878.4 million, up 123.4% year-over-year on an FX neutral basis$11.2 billion Total Payment Volume, up 142.1% year-over-year […]

CHICAGO, Aug. 10, 2020 (GLOBE NEWSWIRE) — International Association of Women (“IAW”) today announced the launch of extended virtual programs. […]

In July, SCYNEXIS announced that it had successfully conducted pre-NDA meetings with the FDA regarding ibrexafungerp for the treatment of […]

WALTHAM, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) today announced the […]